Table 1.
Description of Included Studies
| Study | Type of Patients | Age Range, y | Total No. (HF Events) | Median Follow‐Up (5th–95th Percentile) | Definition of HF | |
|---|---|---|---|---|---|---|
| Study population | Health ABC | Population‐based (elderly persons) | 70.0–80.0 | 3075 (574) | 12.1 (2.0–14.1) | HF hospitalization: confirmation by reviewing hospital records |
| PREDICTOR | Population‐based (elderly persons) | 65.0–86.4 | 2001 (44) | 3.9 (2.5–5.0) | HF hospitalization: main cause of hospital admission=ICD‐9‐CM code 428 | |
| PROSPER | Patients at high risk of developing vascular disease | 70.0–83.4 | 5804 (234) | 3.3 (1.4–3.8) | HF hospitalization: confirmation by reviewing hospital records | |
| External validation | ASCOT | Hypertensive patients | 40.0–80.0 | 19 257 (292) | 5.6 (3.5–6.6) | HF hospitalization and physician‐based diagnosis/HF death |
ASCOT indicates Anglo‐Scandinavian Cardiac Outcomes Trial; Health ABC, Health Aging and Body Composition; HF, heart failure; ICD‐9‐CM, International Classification of Diseases, Ninth Revision, Clinical Modification; PREDICTOR, Valutazione della PREvalenza di DIsfunzione Cardiaca asinTOmatica e di scompenso cardiac; PROSPER, Prospective Study of Pravastatin in the Elderly at Risk.